Susceptibility of human endogenous retrovirus type K to reverse transcriptase inhibitors

Agriculture & Biology

• RNA-directed DNA polymerase 87%
• Retroviridae 87%
• nucleosides 59%
• proviruses 50%
• Human immunodeficiency virus 1 45%
• pathogenicity 44%
• integrase inhibitors 35%
• lamivudine 33%
• genome 30%
• neoplasms 28%
• nervous system diseases 25%
• viruses 23%
• reverse transcription 22%
• proteinase inhibitors 19%
• germ cells 15%
• life cycle (organisms) 15%
• nucleotides 12%
• drugs 12%
• genomics 11%
• infection 9%
• genes 6%
• cells 5%

Medicine & Life Sciences

• Endogenous Retroviruses 100%
• Reverse Transcriptase Inhibitors 88%
• Nucleosides 17%
• Proviruses 14%
• Lamivudine 13%
• HIV-1 9%
• etravirine 9%
• Integrase Inhibitors 8%
• Didanosine 8%
• Stavudine 8%
• Tenofovir 7%
• Zidovudine 6%
• Viral Genome 6%
• Life Cycle Stages 6%
• Human Genome 5%
• Protease Inhibitors 5%
• Virus Replication 5%
• Germ Cells 5%
• Virion 5%
• Nervous System Diseases 5%
• HIV Infections 5%
• Reverse Transcription 4%
• Virulence 4%
• Nucleotides 4%
• Genome 3%
• Viruses 3%
• Neoplasms 3%
• Pharmaceutical Preparations 2%
• Genes 2%